Continental Seed (CONTI)

Score breakdown: P/E: 1/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Piotroski F-Score of 6/9 suggests some recent improvement in financial health and operational efficiency.
• Reported profit growth of 90% and a low PEG of 0.33 indicate the market is pricing in earnings acceleration, though from a low base.
• Latest quarter sales of ₹21 Cr against a market cap of ₹23 Cr implies a low price-to-sales multiple on annualized sales, if sustained.
• Current price of ₹14.85 is above the 52-week low of ₹10.35, showing some support despite the heavy fall from ₹28.50.

Concerns

• Sales have declined sharply by 52.75%, and the latest quarter net profit is ₹0 Cr, pointing to very weak earnings quality.
• P/E of 29.71 is expensive for a low-moat trading business, especially with ROCE of just 4.24%.
• No dividend, no promoter holding data, and no book value/ROE/debt-equity details leave critical information unavailable for analysis.
• The 90% profit growth and 0.33 PEG are misleading if the business cannot sustain even ₹0 Cr quarterly profitability.

AI Analysis

Ben Graham taught me to buy good businesses at a sensible price, not lottery tickets. Continental Seed is a small trading and distribution business with a market cap of just ₹23 Cr. At ₹14.85, the stock trades at 29.71 times earnings. That is a steep multiple for any business, and particularly for a trader in a commodity-like industry where pricing power and moats are typically absent. The numbers give me little confidence. Annual sales have collapsed by 52.75%, and the latest quarter shows sales of ₹21 Cr but net profit of ₹0 Cr. Profit growth of 90% may sound exciting, but it is meaningless if the underlying earning power is zero or fleeting. ROCE is only 4.24%, barely above the cost of capital; this is not a business compounding shareholder value. The PEG ratio of 0.33 assumes rapid profit growth continues, but with sales shrinking and no current quarter profit, that assumption is dangerous. Good investors do not rely on backward-looking growth when the most recent evidence points to deterioration. The Piotroski F-score of 6/9 is one moderate positive, suggesting some recent improvement in financial health, but it does not compensate for the lack of a moat, lack of dividend, and missing data on book value, debt/equity, and promoter holding. As Graham would say, without data on tangible assets and insider ownership, we are investing in the dark. I cannot call this a value investment. It may be a speculation or a potential turnaround, but I need proof of stable sales and genuine margins before committing capital. The price is down from its 52-week high of ₹28.50, but cheap stocks can become cheaper. My discipline says: wait, or walk away.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer